Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 165


Rankl expression predicts poor prognosis in gastric cancer patients: results from a retrospective and single-center analysis.

Zhang X, Song Y, Song N, Zhang L, Wang Y, Li D, Wang Z, Qu X, Liu Y.

Braz J Med Biol Res. 2018 Jan 11;51(3):e6265. doi: 10.1590/1414-431X20176265.


An Rb family-independent E2F3 transcription factor variant impairs STAT5 signaling and mammary gland remodeling during pregnancy in mice.

Liao Y, Du W.

J Biol Chem. 2018 Mar 2;293(9):3156-3167. doi: 10.1074/jbc.RA117.000583. Epub 2018 Jan 12.


KLF5 promotes cervical cancer proliferation, migration and invasion in a manner partly dependent on TNFRSF11a expression.

Ma D, Chang LY, Zhao S, Zhao JJ, Xiong YJ, Cao FY, Yuan L, Zhang Q, Wang XY, Geng ML, Zheng HY, Li O.

Sci Rep. 2017 Nov 16;7(1):15683. doi: 10.1038/s41598-017-15979-1.


RANK rewires energy homeostasis in lung cancer cells and drives primary lung cancer.

Rao S, Sigl V, Wimmer RA, Novatchkova M, Jais A, Wagner G, Handschuh S, Uribesalgo I, Hagelkruys A, Kozieradzki I, Tortola L, Nitsch R, Cronin SJ, Orthofer M, Branstetter D, Canon J, Rossi J, D'Arcangelo M, Botling J, Micke P, Fleur L, Edlund K, Bergqvist M, Ekman S, Lendl T, Popper H, Takayanagi H, Kenner L, Hirsch FR, Dougall W, Penninger JM.

Genes Dev. 2017 Oct 15;31(20):2099-2112. doi: 10.1101/gad.304162.117. Epub 2017 Nov 8.


Increased breast tissue receptor activator of nuclear factor-κB ligand (RANKL) gene expression is associated with higher mammographic density in premenopausal women.

Toriola AT, Dang HX, Hagemann IS, Appleton CM, Colditz GA, Luo J, Maher CA.

Oncotarget. 2017 May 17;8(43):73787-73792. doi: 10.18632/oncotarget.17909. eCollection 2017 Sep 26.


RANKL-mediated harmonious dialogue between fetus and mother guarantees smooth gestation by inducing decidual M2 macrophage polarization.

Meng YH, Zhou WJ, Jin LP, Liu LB, Chang KK, Mei J, Li H, Wang J, Li DJ, Li MQ.

Cell Death Dis. 2017 Oct 12;8(10):e3105. doi: 10.1038/cddis.2017.505.


Mechanism of M-cell differentiation accelerated by proliferation of indigenous bacteria in rat Peyer's patches.

Yuasa H, Mantani Y, Masuda N, Nishida M, Arai M, Yokoyama T, Tsuruta H, Kawano J, Hoshi N, Kitagawa H.

J Vet Med Sci. 2017 Nov 17;79(11):1826-1835. doi: 10.1292/jvms.17-0470. Epub 2017 Oct 8.


The RANK/RANKL/OPG system in tumorigenesis and metastasis of cancer stem cell: potential targets for anticancer therapy.

Sisay M, Mengistu G, Edessa D.

Onco Targets Ther. 2017 Jul 27;10:3801-3810. doi: 10.2147/OTT.S135867. eCollection 2017. Review.


Circulating RANKL and RANKL/OPG and Breast Cancer Risk by ER and PR Subtype: Results from the EPIC Cohort.

Sarink D, Schock H, Johnson T, Overvad K, Holm M, Tjønneland A, Boutron-Ruault MC, His M, Kvaskoff M, Boeing H, Lagiou P, Papatesta EM, Trichopoulou A, Palli D, Pala V, Mattiello A, Tumino R, Sacerdote C, Bueno-de-Mesquita HBA, van Gils CH, Peeters PH, Weiderpass E, Agudo A, Sánchez MJ, Chirlaque MD, Ardanaz E, Amiano P, Khaw KT, Travis R, Dossus L, Gunter M, Rinaldi S, Merritt M, Riboli E, Kaaks R, Fortner RT.

Cancer Prev Res (Phila). 2017 Sep;10(9):525-534. doi: 10.1158/1940-6207.CAPR-17-0125. Epub 2017 Jul 12.


The association between the baseline bone resorption marker CTX and incident dysglycemia after 4 years.

Liu TT, Liu DM, Xuan Y, Zhao L, Sun LH, Zhao DD, Wang XF, He Y, Guo XZ, Du R, Wang JQ, Liu JM, Zhao HY, Tao B.

Bone Res. 2017 Jul 4;5:17020. doi: 10.1038/boneres.2017.20. eCollection 2017.


Denosumab: an Emerging Therapy in Pediatric Bone Disorders.

Boyce AM.

Curr Osteoporos Rep. 2017 Aug;15(4):283-292. doi: 10.1007/s11914-017-0380-1. Review.


Correlation of mammographic density and serum calcium levels in patients with primary breast cancer.

Hack CC, Stoll MJ, Jud SM, Heusinger K, Adler W, Haeberle L, Ganslandt T, Heindl F, Schulz-Wendtland R, Cavallaro A, Uder M, Beckmann MW, Fasching PA, Bayer CM.

Cancer Med. 2017 Jun;6(6):1473-1481. doi: 10.1002/cam4.1066. Epub 2017 May 2.


Administration of RANKL boosts thymic regeneration upon bone marrow transplantation.

Lopes N, Vachon H, Marie J, Irla M.

EMBO Mol Med. 2017 Jun;9(6):835-851. doi: 10.15252/emmm.201607176.


Deletion of a Distal RANKL Gene Enhancer Delays Progression of Atherosclerotic Plaque Calcification in Hypercholesterolemic Mice.

Shamsuzzaman S, Onal M, St John HC, Pike JW.

J Cell Biochem. 2017 Dec;118(12):4240-4253. doi: 10.1002/jcb.26074. Epub 2017 May 30.


Osteoblast-osteoclast interactions.

Chen X, Wang Z, Duan N, Zhu G, Schwarz EM, Xie C.

Connect Tissue Res. 2018 Mar;59(2):99-107. doi: 10.1080/03008207.2017.1290085. Epub 2017 Mar 21.


Osteoprotegerin and breast cancer risk by hormone receptor subtype: a nested case-control study in the EPIC cohort.

Fortner RT, Sarink D, Schock H, Johnson T, Tjønneland A, Olsen A, Overvad K, Affret A, His M, Boutron-Ruault MC, Boeing H, Trichopoulou A, Naska A, Orfanos P, Palli D, Sieri S, Mattiello A, Tumino R, Ricceri F, Bueno-de-Mesquita HB, Peeters PH, Van Gils CH, Weiderpass E, Lund E, Quirós JR, Agudo A, Sánchez MJ, Chirlaque MD, Ardanaz E, Dorronsoro M, Key T, Khaw KT, Rinaldi S, Dossus L, Gunter M, Merritt MA, Riboli E, Kaaks R.

BMC Med. 2017 Feb 8;15(1):26. doi: 10.1186/s12916-017-0786-8.


Aberrant regulation of RANKL/OPG in women at high risk of developing breast cancer.

Kiechl S, Schramek D, Widschwendter M, Fourkala EO, Zaikin A, Jones A, Jaeger B, Rack B, Janni W, Scholz C, Willeit J, Weger S, Mayr A, Teschendorff A, Rosenthal A, Fraser L, Philpott S, Dubeau L, Keshtgar M, Roylance R, Jacobs IJ, Menon U, Schett G, Penninger JM.

Oncotarget. 2017 Jan 17;8(3):3811-3825. doi: 10.18632/oncotarget.14013.


Hormonal Modulation of Breast Cancer Gene Expression: Implications for Intrinsic Subtyping in Premenopausal Women.

Bernhardt SM, Dasari P, Walsh D, Townsend AR, Price TJ, Ingman WV.

Front Oncol. 2016 Nov 14;6:241. eCollection 2016. Review.


Loss of glutaredoxin 3 impedes mammary lobuloalveolar development during pregnancy and lactation.

Pham K, Dong J, Jiang X, Qu Y, Yu H, Yang Y, Olea W, Marini JC, Chan L, Wang J, Wehrens XH, Cui X, Li Y, Hadsell DL, Cheng N.

Am J Physiol Endocrinol Metab. 2017 Mar 1;312(3):E136-E149. doi: 10.1152/ajpendo.00150.2016. Epub 2016 Nov 15.


Plasma osteoprotegerin and breast cancer risk in BRCA1 and BRCA2 mutation carriers.

Odén L, Akbari M, Zaman T, Singer CF, Sun P, Narod SA, Salmena L, Kotsopoulos J.

Oncotarget. 2016 Dec 27;7(52):86687-86694. doi: 10.18632/oncotarget.13417.

Supplemental Content

Support Center